{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:46:24Z","timestamp":1792525584241,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117540","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:41:33Z","timestamp":1792424493000},"page":"117540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["AAV-mediated Siglecf elimination on TAMs reverses TMZ therapy-induced T cell dysfunction in glioblastoma"],"prefix":"10.1016","volume":"191","author":[{"given":"Zhenkun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhening","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.117540_bb0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117540_bb0010","doi-asserted-by":"crossref","unstructured":"R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R.C. Janzer, S.K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, R.O. Mirimanoff, R. European Organisation for, T. Treatment of Cancer Brain, G. Radiotherapy, G. National Cancer Institute of Canada Clinical Trials, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N. Engl. J. Med. 352(10) (2005) 987\u201396.","DOI":"10.1056\/NEJMoa043330"},{"issue":"3","key":"10.1016\/j.intimp.2026.117540_bb0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis"},{"key":"10.1016\/j.intimp.2026.117540_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107922","article-title":"Genotoxic therapy and resistance mechanism in gliomas","volume":"228","author":"Lang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2026.117540_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216593","article-title":"Neovascularization directed by CAVIN1\/CCBE1\/VEGFC confers TMZ-resistance in glioblastoma","volume":"582","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.intimp.2026.117540_bb0030","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1021\/acsnano.1c09794","article-title":"Nano-Codelivery of Temozolomide and siPD-L1 to reprogram the drug-resistant and immunosuppressive microenvironment in Orthotopic glioblastoma","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.117540_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117540_bb0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/imm.13488","article-title":"TIM3\/CEACAM1 pathway involves in myeloid-derived suppressor cells induced CD8(+) T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome","volume":"168","author":"Yu","year":"2023","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0045","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/jcmm.14825","article-title":"CD8(+) T cells exhaustion induced by myeloid-derived suppressor cells in myelodysplastic syndromes patients might be through TIM3\/Gal-9 pathway","volume":"24","author":"Tao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117540_bb0050","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117540_bb0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/ijms19020436","article-title":"When immune cells turn bad-tumor-associated microglia\/macrophages in glioma","volume":"19","author":"Roesch","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117540_bb0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","article-title":"Macrophage regulation of tumor responses to anticancer therapies","volume":"23","author":"De Palma","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.intimp.2026.117540_bb0065","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","article-title":"Spatiotemporal co-dependency between macrophages and exhausted CD8(+) T cells in cancer","volume":"40","author":"Kersten","year":"2022","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.intimp.2026.117540_bb0070","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","article-title":"Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer","volume":"55","author":"Nixon","year":"2022","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2026.117540_bb0075","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41416-022-01887-3","article-title":"Macrophage-derived CCL23 upregulates expression of T-cell exhaustion markers in ovarian cancer","volume":"127","author":"Kamat","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0080","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41420-021-00556-3","article-title":"M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p\/YOD1\/YAP\/beta-catenin pathway","volume":"7","author":"Pu","year":"2021","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.intimp.2026.117540_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.trecan.2023.11.009","article-title":"Targeting myeloid cells for cancer immunotherapy: Siglec-7\/9\/10\/15 and their ligands","volume":"10","author":"Boelaars","year":"2024","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0090","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2026.117540_bb0095","first-page":"1161","article-title":"Temozolomide promotes immune escape of GBM cells via upregulating PD-L1","volume":"9","author":"Wang","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"7769","key":"10.1016\/j.intimp.2026.117540_bb0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.intimp.2026.117540_bb0105","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2026.117540_bb0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"issue":"6190","key":"10.1016\/j.intimp.2026.117540_bb0115","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.intimp.2026.117540_bb0120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.intimp.2026.117540_bb0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2026.117540_bb0135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry A"},{"issue":"4","key":"10.1016\/j.intimp.2026.117540_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058201","article-title":"Text mining effectively scores and ranks the literature for improving chemical-gene-disease curation at the comparative toxicogenomics database","volume":"8","author":"Davis","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2026.117540_bb0145","article-title":"Immune microenvironment in glioblastoma subtypes","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0092-8674(02)00677-3","article-title":"The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification","volume":"109","author":"Zhou","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117540_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00532","article-title":"Crosstalk between PD-1\/PD-L1 blockade and its combinatorial therapies in tumor immune microenvironment: a focus on HNSCC","volume":"8","author":"Lin","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","article-title":"Brain immunology and immunotherapy in brain tumours","volume":"20","author":"Sampson","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117540_bb0165","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1038\/ncomms9698","article-title":"Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2","volume":"6","author":"Oh","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2026.117540_bb0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1215\/15228517-2006-008","article-title":"The role of human glioma-infiltrating microglia\/macrophages in mediating antitumor immune responses","volume":"8","author":"Hussain","year":"2006","journal-title":"Neuro Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117540_bb0175","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2026.117540_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101112","article-title":"Siglec receptors as new immune checkpoints in cancer","volume":"90","author":"Stanczak","year":"2023","journal-title":"Mol. Aspects Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117540_bb0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.trecan.2017.04.001","article-title":"The untold story of Granzymes in Oncoimmunology: novel opportunities with old acquaintances","volume":"3","author":"Arias","year":"2017","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2026.117540_bb0190","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/blood-2005-02-0817","article-title":"The tumor suppressor TSLC1\/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM","volume":"106","author":"Boles","year":"2005","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.intimp.2026.117540_bb0195","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1073\/pnas.1219888110","article-title":"Targeted delivery of lipid antigen to macrophages via the CD169\/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation","volume":"110","author":"Kawasaki","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0200","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1525243","article-title":"Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma","volume":"8","author":"Park","year":"2019","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.intimp.2026.117540_bb0205","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/neuonc\/noab003","article-title":"PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma","volume":"23","author":"Wu","year":"2021","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12885-024-12017-y","article-title":"p53\/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme","volume":"24","author":"Meng","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13046-022-02291-8","article-title":"Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117540_bb0220","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.intimp.2026.117540_bb0225","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/2159-8290.CD-21-1434","article-title":"Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal Cancer patients","volume":"12","author":"Crisafulli","year":"2022","journal-title":"Cancer Discov."},{"issue":"6583","key":"10.1016\/j.intimp.2026.117540_bb0230","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.intimp.2026.117540_bb0235","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117540_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02642","article-title":"Disruption of IL-33 signaling limits early CD8+ T cell effector function leading to exhaustion in murine hemophagocytic lymphohistiocytosis","volume":"9","author":"Rood","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117540_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215598","article-title":"PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer","volume":"532","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13046-024-03050-7","article-title":"Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM\/PD-L1 signaling","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117540_bb0255","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2026.117540_bb0260","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.it.2017.12.005","article-title":"SIRPalpha-CD47 immune checkpoint blockade in anticancer therapy","volume":"39","author":"Veillette","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.117540_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.929339","article-title":"Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages","volume":"13","author":"Zeller","year":"2022","journal-title":"Front. Immunol."},{"issue":"705","key":"10.1016\/j.intimp.2026.117540_bb0270","doi-asserted-by":"crossref","first-page":"eadf5302","DOI":"10.1126\/scitranslmed.adf5302","article-title":"Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma","volume":"15","author":"Schmassmann","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.117540_bb0275","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","article-title":"Siglec-9 regulates an effector memory CD8(+) T-cell subset that congregates in the melanoma tumor microenvironment","volume":"7","author":"Haas","year":"2019","journal-title":"Cancer Immunol. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:36:37Z","timestamp":1792524997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":55,"alternative-id":["S1567576926013883"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117540","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-mediated Siglecf elimination on TAMs reverses TMZ therapy-induced T cell dysfunction in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117540"}}